|
Post by cm5 on May 17, 2016 15:48:40 GMT -5
|
|
|
Post by cm5 on May 14, 2016 17:57:17 GMT -5
So, $140,000 to $211,400 over 34 years of life (for diagnosis, both sexes, age 40) vs 20,000 (2015 cases receiving course of Xtandi) x ave cost treatment course (less than 1 year) of $129,000.
Or---Lots of dollars over many years into many pockets-------vs. ---------Lots of dollars over less than a year into a few pockets-------
|
|
|
Post by cm5 on May 14, 2016 10:29:04 GMT -5
Apples and Oranges, Costs and Values---A View from Afar---
AFFIRM Phase III clinical trial of the drug Enzalutamide (Xtandi)show the drug extends life by an average five months in the most advanced stages of prostate cancer.
Enzalutamide in Prostate Cancer after Chemotherapy
N Engl J Med 2012; 367:2448-2449 December 20, 2012DOI: 10.1056/NEJMc1212940
|
|
|
Post by cm5 on May 14, 2016 9:51:51 GMT -5
|
|
|
Post by cm5 on May 5, 2016 21:14:35 GMT -5
Time to reread post by pantaloons on April 20, 2016 at 2:37pm.
|
|
|
Post by cm5 on May 5, 2016 20:48:43 GMT -5
Reposting thekindaguyiyam's find below:
The countdown to lift off is accelerating----
|
|
|
Post by cm5 on May 4, 2016 13:47:07 GMT -5
Re: Oral Insulin---
There as a recent thread about Mannkind's patent on oral insulin.
|
|
|
Post by cm5 on May 3, 2016 19:05:30 GMT -5
Chris Leach---- Insulin Nation insulinnation.com/treatment/inhalable-insulin-a-breathtaking-development/
Chris Leach was the founding editor of numerous diabetes publications, including Insulin Nation, Type 2 Nation, and Health Matters. A lifelong entrepreneur, he also founded New Jersey Monthly and was part of the team that created ESPN, the Magazine. Chris passed away in 2013. Published by Chris Leach: The Mouse Trap, 18 Nov 2013 in Cure Insight & Treatment Easier Pens For 2014?, 15 Nov 2013 in Research & Wearables/Products Tandem and the Future of Pumps, 23 Oct 2013 in Pumps Daily Pill May Help T1s Lower A1c and Reduce Insulin Use, 15 Oct 2013 in Medicine/Drugs & Treatment Artificial Pancreas: What’s in a Name?, 04 Oct 2013 in Artificial Pancreas Medtronic’s “Artificial Pancreas” Gains FDA Approval, 02 Oct 2013 in Artificial Pancreas A Simpler Approach To Treating Hypos, 27 Sep 2013 in Hypoglycemia RIP, A1cNow, 25 Sep 2013 in Meters & CGMs Good Vibrations: A New Approach to Treating Neuropathy, 19 Sep 2013 in Treatment & Wearables/Products A Memorable App, 11 Sep 2013 in Pumps Back to the Future for Cancer Drug That May Help Type 1s, 05 Sep 2013 in Medicine/Drugs The Cure is in Us, 03 Sep 2013 in Cure Insight Afrezza Enters the Home Stretch…Again, 22 Aug 2013 in Medicine/Drugs Better Math, Smarter Meters, 15 Aug 2013 in Meters & CGMs Test Strip Accuracy: Blood In, Garbage Out?, 01 Aug 2013 in Meters & CGMs Sleep Apnea in Kids: A Total Nightmare, 30 Jul 2013 in Living & Treatment A New Role For “Misplaced Parents?”, 19 Jul 2013 in Living & Treatment Harnessing Hypos: Glucagon As An Everyday Tool, 17 Jul 2013 in Hypoglycemia Pumping Glucagon: The Unusual Case of Randy Brown, 16 Jul 2013 in Hypoglycemia ADA Scientific Sessions 2013: A Pause Before The “Next Big Thing”, 27 Jun 2013 in Cure Insight & Medicine/Drugs & Wearables/Products insulinnation.com/author/chris-leach/
|
|
|
Post by cm5 on May 3, 2016 18:46:07 GMT -5
|
|
|
Post by cm5 on May 3, 2016 18:34:23 GMT -5
|
|
|
Post by cm5 on May 1, 2016 19:14:47 GMT -5
Perhaps you could reach out to the author of the article, Cindy Kuzma, asking that the spelling of Afrezza be corrected?
Only one of us should do this, so as not to be annoying---
|
|
|
Post by cm5 on May 1, 2016 17:40:47 GMT -5
More for fellow nerds and nerdettes:
As Matt pointed out, this is a term in Roman law----ie, Latin.
u·su·fruct sounds like ˈyo͞ozəˌfrəkt
The right to enjoy the use and advantages of another's property short of the destruction or waste of its substance.
|
|
|
Post by cm5 on May 1, 2016 16:59:51 GMT -5
Generic Insulin in Late Stage Development-----more disruption coming for the major US pharmaceutical producers of insulin:
Lannett To Co-Develop Generic Insulin Product For $21 Billion U.S. Market
Lannett Has Exclusive U.S. Marketing Rights to Insulin Product; Fifth Project with Strategic Partner--
|
|
|
Post by cm5 on May 1, 2016 11:35:48 GMT -5
"When an idea reaches critical mass there is no stopping the shift its presence will induce."
Marianne Williamson
|
|
|
Post by cm5 on May 1, 2016 9:51:40 GMT -5
|
|